Manitoba to invest in diagnostics, joint procedures & cancer care
This article was originally published in Clinica
Executive Summary
Canada's Manitoba province is investing Can$155m (US$131m) in its wait-time reduction strategy. Initial investments will be used to increase diagnostics, joint-replacement procedures, and community cancer programmes.